3 Ways DealMaker Offers Better Payments for Capital Raises

January 14, 2022

Traditionally, in the process of raising capital, investor “payments” are considered an afterthought— the company raising capital opens an escrow account; investors wire money into that escrow account, and an accountant or corporate secretary manually reconciles each wire received to a signed subscription agreement. If the process is “fast”, it is completed in a matter of weeks

In years past, online capital formation has been much the same. Investors are offered credit card and “e-check” ACH, where an investor enters bank account information on screen, but funds are nevertheless deposited into escrow and disbursed manually; a slow and tedious process. At DealMaker, our breakthrough came with the realization that credit cards were a valuable tool, but would not suffice alone; rather digital, cardless payments represent the future of online capital raising. 

Let’s highlight three ways DealMaker’s best-in-class payments technology accelerates online capital formation.

1. Bank-to-Bank Payments Minimize Fees and Increases Conversion


On DealMaker, an investor submitting a payment is presented with the option to connect their bank account and pay with the click of a button, seamlessly logging into their online banking portal directly on the application. When that same investor returns to transact in another offering (or re-invest in the same), their account is still connected, and their checkout process is further simplified. Our technology has made paying for an investment as easy as sending a Venmo. 

While other platforms often boast of high, 70%+ card adoption rates, we are proud of our platform-wide 40/30/30 credit card/bank-to-bank/express wire split saving millions of dollars in processing fees and minimizing costly chargeback risks.

2. Wires are Automatically Reconciled and Minimizes Delays and Errors

There’s a “good enough” bifurcation that other investment platforms have accepted as the status quo— “pull” payments (i.e credit card and bank-to-bank) are automatic, but “push” payments (i.e wires) are reconciled manually, by hand. This “old school” way of thinking costs millions of dollars in wasted time and errors: wire transfers often represent the largest investments, yet their timely clearance relies on manual accounting, prone to delays and mistakes. On DealMaker, wires are automatic— when an investor opts to wire, a unique virtual bank account is generated for their specific transaction. As soon as their wire is received, it is automatically reconciled and the investor is notified. 

While other platforms have entire accounting teams to reconcile omnibus escrow accounts, DealMaker has fully automated the process to save issuers time and money.


3. Payouts are Automatic and Enable Faster Access to Capital

The use of digital platforms for capital formation has historically required the use of escrow, adding another inefficient hurdle to the process of accepting payments. Issuers are forced to coordinate manual “closings'' to disburse funds, burdened with fees and delays. Our technology allows issuers to connect their bank accounts directly, accepting and disbursing investment proceeds on an automatic or rolling basis, the same way a merchant does with an online store

Taken together, bank-to-bank transfers and express wires allow for higher conversion and faster closings. By not mandating escrow and automating payouts, DealMaker provides issuers with quicker access to their capital than any other technology stack.


Better Investments Means Better Opportunities

DealMaker offers companies raising capital a Shopify-style solution to accept investments directly from their own website, like a checkout for an online store. Our technology has powered over 400 issuers to raise over $1 billion online.

NOTICE: Some issuers may require escrow for their offerings due to legal, jurisdictional, or other compliance requirements. Use of DealMaker Payments is contingent on approval by third-party payment processors as well as compliance review of issuer and its directors.

Interested in learning more about our payments solutions? Get in touch.

Ben Barrett

Senior Manager, Strategy & Operations

Ben currently leads DealMaker's strategy and operations, and focuses on integrating new business and product lines efficiently and seamlessly with DealMaker's existing product. Additionally, Ben leads payments strategy, ensuring that DealMaker's payments remain best-in-class, and that it constantly evolves. Ben has also worked cross-functionally across Customer Service, Sales and Finance/Back-Office before his current role.

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

Monogram at NASDAQ celebration

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

  • Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
  • Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
  • A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
  • Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date End Date Type Platform Amount Raised # Investors
3/13/193/31/20A+SeedInvest$14,588,6686,000
11/16/201/16/21A+StartEngine$2,965,5018,000
1/17/212/18/22A+StartEngine$23,647,85314,082
7/15/223/16/23CFDealMaker$4,673,0002,249
3/1/234/8/23A+Republic$232,275120
3/1/235/23/23A+DealMaker$15,958,3645,198
5/18/23-Nasdaq listing
7/2410/24Unit OfferingDealMaker$12,990,1032,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+
Raised across seven campaigns
~40,000
Investors championing Monogram's vision
20%
Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

  • Filed its first patent application in 2017
  • Conducted clinical studies at UCLA and University of Nebraska
  • Expanded the team with key hires
  • Attracted a top-tier advisory board to guide clinical innovations
  • Signed their first distribution partnerships
  • Made headlines with cutting-edge live demonstrations
  • Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

  • Go from concept to commercialization without relying on VCs
  • Retain ownership and control in a high-burn industry
  • Build a base of loyal shareholders who invested not once, but over and over again
  • Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Dr. Doug Unis Quote
Ben Sexson Quote

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker
DealMaker Logo

The ultimate technology for raising capital online

Talk to the experts
The ultimate technology for raising capital online - talk to the experts